When One Pathway Serves Two Masters

When One Pathway Serves Two Masters: What Blood Vessels Teach Us About Fixing Lazy Eye*The hook:* This week, researchers published a breakthrough on the angiopoietin-Tie pathway — the molecular 'switch' that tells blood vessels whether to mature/stabilize (growth) or open up for immune cells (inflammation). Same receptors, same ligands, opposite outcomes. The difference? Context — timing, mechanical forces, and co-receptors.The bridge: Amblyopia is a context problem, too. The visual cortex has the wiring for binocular vision, but early-life blur or misalignment flips the brain's 'switch' to suppression — the neural equivalent of chronic inflammation. The weak eye's signals are actively inhibited.The product: AmblyoPunch (Meta Quest) doesn't patch the strong eye and hope. It runs a four-stage dichoptic curriculum inside a genuine VR game: punch Gabor-pattern coins, dodge red spikes, progress through six worlds. Stage 1 warms up the lazy eye alone. Stage 2 dims the strong eye to break suppress.

Product: https://www.meta.com/en-gb/experiences/amblyopunch/1239507485902689/